CB
CeriBell, Inc.
CBLL · NASDAQ
$23.63 +0.90% (+$0.21)
1M +1.63%
Market Cap $932.3M
P/E Ratio -
Div. Yield -
ROE 44.85%
Piotroski F-Score Weak
2/9Valuation
5 /100
Expensive P/S 9.14x
P/B 7.27x
P/E N/A
Growth
100 /100
Growing Rev. growth 50.90%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 88.90%
FCF margin 55.25%
Net margin 64.73%
Quality
8 /100
Poor ROIC 46.54%
Asset turnover 0.61x
ROE 44.85%
Debt
69 /100
Low Debt/Equity 0.17x
Int. coverage -35.38x
Current ratio 9.18x
Stability
42 /100
Moderate Beta 0.81x
Profitable years 0
Rev. volatility 20.13%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CBLL
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Xingjuan Chao
Employees
327
Headquarters
Sunnyvale
Upcoming events
03 NOV
Earnings
Upcoming earnings report